Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation

Authors

  • Piotr K. Krajewski
  • Joanna Maj
  • Jacek C. Szepietowski Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, ul. Chalubinskiego 1, PL-50-368 Wrocław, Poland

DOI:

https://doi.org/10.2340/00015555-3729

Keywords:

SARS-CoV2 infection, COVID-19, neurological symptoms

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020; 288: 192-206.

DOI: https://doi.org/10.1111/joim.13091

Mahase E. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction. BMJ 2020; 368: m1036.

DOI: https://doi.org/10.1136/bmj.m1036

Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020; 22: 19.

DOI: https://doi.org/10.1186/s12575-020-00128-2

Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 2020; 77: 8-12.

DOI: https://doi.org/10.1016/j.jocn.2020.05.017

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382: 2268-2270.

DOI: https://doi.org/10.1056/NEJMc2008597

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-690.

DOI: https://doi.org/10.1001/jamaneurol.2020.1127

Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun 2020; 88: 11-16.

DOI: https://doi.org/10.1016/j.bbi.2020.05.037

Merskey H, International Association for the Study of P, Task Force on T. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP; 2002.

Yamada K, Kubota Y, Shimizu Y, Cui R, Mori Y, Okuno Y, et al. Sleep shortage is associated with postherpetic neuralgia development through hyperesthesia and acute pain intensity: a community-based prospective cohort study. Pain Pract 2019; 19: 476-483.

DOI: https://doi.org/10.1111/papr.12766

Krajewski PK, Szepietowski JC, Maj J. Cutaneous hyperesthesia: a novel manifestation of COVID-19. Brain Behav Immun 2020; 87: 188.

DOI: https://doi.org/10.1016/j.bbi.2020.05.064

Moutal A, Martin LF, Boinon L, Gomez K, Ran D, Zhou Y, et al. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain 2020 Oct 1 [Online ahead of print].

DOI: https://doi.org/10.1097/j.pain.0000000000002097

Weekes CD, Beeram M, Tolcher AW, Papadopoulos KP, Gore L, Hegde P, et al. A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors. Invest New Drugs 2014; 32: 653-660.

DOI: https://doi.org/10.1007/s10637-014-0071-z

Published

2021-01-05

How to Cite

Krajewski, P. K., Maj, J., & Szepietowski, J. C. (2021). Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation. Acta Dermato-Venereologica, 101(1), adv00366. https://doi.org/10.2340/00015555-3729

Issue

Section

Short Communication

Categories